Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

NCT00663689 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Brain Metastases

Interventions

DRUG: erlotinib

Sponsor

Guangdong Provincial People's Hospital